Kane Biotech Inc Share Price Toronto S.E.
Equities
KNE
CA4838092084
Biotechnology & Medical Research
Sales 2022 | 2.67M 1.95M 153M | Sales 2023 | 149K 109K 8.56M | Capitalization | 10.55M 7.72M 606M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.19M -172M | Net income 2023 | -5M -3.66M -287M | EV / Sales 2022 | 6.37 x |
Net Debt 2022 | 5.76M 4.21M 331M | Net Debt 2023 | 8.51M 6.23M 489M | EV / Sales 2023 | 128 x |
P/E ratio 2022 |
-2.79
x | P/E ratio 2023 |
-2.02
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.07% |
Latest transcript on Kane Biotech Inc
Managers | Title | Age | Since |
---|---|---|---|
Marc Edwards
CEO | Chief Executive Officer | - | 01/06/16 |
Ray Dupuis
DFI | Director of Finance/CFO | - | 04/09/17 |
Gregory Schultz
CTO | Chief Tech/Sci/R&D Officer | 73 | 04/04/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Renaud
BRD | Director/Board Member | - | 14/09/10 |
Chairman | 59 | 02-19 | |
Georges Morin
BRD | Director/Board Member | - | 19/05/20 |
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |